DEF 14A

Company

Anika Therapeutics, Inc.

Filed

April 23, 1999

Period of Report

June 3, 1999

Accession Number

0001047469-99-016053

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →